Our results based on the SangerBox database demonstrated that SERPINA1 expression was significantly connected to ICP genes in most cancer types, especially GBMLGG, OV, KIPAN, and PRAD, which suggested that patients with these cancers may respond well to ICB treatment. The gene discussed is SERPINA1; the disease is cancer.